Ticker LaunchReverse merger · Completed · QLGN
Qualigen, Inc.
Reverse merger with Ritter Pharmaceuticals, Inc.
Qualigen, Inc. merged into Ritter Pharmaceuticals, Inc., a Nasdaq-listed gut-microbiome therapeutics developer that ended its legacy business, in a reverse merger that takes the private company public. The deal was announced on Jan 15, 2020 and closed on May 22, 2020. The combined company trades as Qualigen Therapeutics, Inc. (QLGN) on Nasdaq.
Qualigen Therapeutics develops therapeutics for cancer and infectious diseases and sells the FastPack rapid diagnostic platform. It became public by merging Qualigen, Inc. into Ritter Pharmaceuticals, with Qualigen directors and officers taking over the combined company.
- Status
- Completed
- Private company
- Qualigen, Inc.
- Public company
- Ritter Pharmaceuticals, Inc.
- Public company business before
- Nasdaq-listed gut-microbiome therapeutics developer that ended its legacy business
- Announced
- Jan 15, 2020
- Closed
- May 22, 2020
- Combined company
- Qualigen Therapeutics, Inc. (QLGN)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Concurrent financing and investors
- Contingent value rights (CVR)
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Form 8-K (completion of acquisition) May 29, 2020
- Press release (Exhibit 99)
- All filings on EDGAR CIK 1460702
Other completed reverse mergers
- AYRO, Inc. (AYRO Operating Company)into DropCar, Inc. · May 28, 2020
- Chondrial Therapeutics, Inc.into Zafgen, Inc. · May 28, 2020
- GSL Healthcare, Inc.into Agentix Corp. · May 28, 2020
- Histogen Inc.into Conatus Pharmaceuticals Inc. · May 26, 2020
- Forta Financial Group, Inc.into Financial Gravity Companies, Inc. · May 21, 2020
- Timber Pharmaceuticals LLCinto BioPharmX Corporation · May 18, 2020